HER2 overexpression has been found to be more prevalent in certain subtypes of GC, specifically intestinal type, when compared to diffuse or mixed type, with rates of 31% and 6%, respectively [22,24,32]. The gene discussed is ERBB2; the disease is gastric cancer.